Skip to main content
Erschienen in: World Journal of Pediatrics 11/2022

12.08.2022 | Commentaries

Neutropenia: diagnosis and management

verfasst von: Jing Zhang, Xiao-Yan Wu, Run-Ming Jin

Erschienen in: World Journal of Pediatrics | Ausgabe 11/2022

Einloggen, um Zugang zu erhalten

Excerpt

Neutropenia is defined as an absolute neutrophil count (ANC) of less than 1500/μL. According to the number of circulating neutrophils, neutropenia is divided into mild (1000/μL ≤ ANC < 1500/μL), moderate (500/μL ≤ ANC < 1000/μL), and severe (ANC < 500/μL) [1]. The etiology of neutropenia is shown in Table 1. The most common causes of neutropenia are pathogen infections. Other causes include immune disorders, malignant diseases and other hematolohic diseases, malnutrition, and the use of drugs. Congenital neutropenia is relatively rare, with a prevalence of 3–8.5 cases per million [2]. Excluding these causes, neutropenia lasting for more than three months is known as chronic idiopathic neutropenia (CIN) [3].
Table 1
Etiology of neutropenia
Reasons
 
Infections
Bacterial infections: rickettsia, brucella, typhoid, tuberculosis, etc.
Viral infections: chickenpox virus, cytomegalovirus, measles virus, Epstein-Barr virus (EBV), parvovirus B19, etc.
Other infections: fungus, chlamydia, etc.
Drugs
Chemotherapeutic agents: cyclosporine, cyclophosphamide, decitabine, carboplatin, etc.
Other drugs: antibiotics, antithyroids;antipsychotics, anticonvulsant, antirheumatics, non-steroidal anti-inflammatory drugs, etc.
Gene defects
Severe congenital neutropenia, cyclic neutropenia, syndromic congenital neutropenia: Shwachman-bodian-Diamond syndrome, Chédiak-higashi syndrome, Barth syndrome, etc.
Malignant diseases and other hematologic diseases
Leukemia, myelodysplastic syndrome, thymic tumors, aplastic anemia, etc.
Immune diseases
Systemic autoimmune diseases such as systemic lupus erythematosus, rheumatoid arthritis, etc.; alloimmune neutropenia; autoimmune neutropenia
Other
Ethnic benign neutropenia
Nutritional deficiencies: deficiencies of protein, vitamin B12, folic acid, etc.
Idiopathic
 
Literatur
1.
Zurück zum Zitat Palmblad JEW, von Dem Borne AEGK. Idiopathic, immune, infectious, and idiosyncratic neutropenias. Semin Hematol. 2002;39:113.CrossRef Palmblad JEW, von Dem Borne AEGK. Idiopathic, immune, infectious, and idiosyncratic neutropenias. Semin Hematol. 2002;39:113.CrossRef
2.
Zurück zum Zitat Carlsson G, Fasth A, Berglöf E, Lagerstedt-Robinson K, Nordenskjöld M, Palmblad J, et al. Incidence of severe congenital neutropenia in Sweden and risk of evolution to myelodysplastic syndrome/leukaemia. Brit J Haematol. 2012;158:363–9.CrossRef Carlsson G, Fasth A, Berglöf E, Lagerstedt-Robinson K, Nordenskjöld M, Palmblad J, et al. Incidence of severe congenital neutropenia in Sweden and risk of evolution to myelodysplastic syndrome/leukaemia. Brit J Haematol. 2012;158:363–9.CrossRef
3.
Zurück zum Zitat Papadaki HA, Palmblad J, Eliopoulos GD. Non-immune chronic idiopathic neutropenia of adult: an overview. Eur J Haematol. 2001;67:35–44.CrossRef Papadaki HA, Palmblad J, Eliopoulos GD. Non-immune chronic idiopathic neutropenia of adult: an overview. Eur J Haematol. 2001;67:35–44.CrossRef
4.
Zurück zum Zitat Newburger PE. Autoimmune and other acquired neutropenias. Hematology. 2016;2016:38–42.CrossRef Newburger PE. Autoimmune and other acquired neutropenias. Hematology. 2016;2016:38–42.CrossRef
5.
Zurück zum Zitat Brown KE, Young NS. Parvoviruses and bone marrow failure. Stem Cells (Dayton, Ohio). 1996;14:151–63.CrossRef Brown KE, Young NS. Parvoviruses and bone marrow failure. Stem Cells (Dayton, Ohio). 1996;14:151–63.CrossRef
6.
Zurück zum Zitat Bhatt V, Saleem A. Review: drug-induced neutropenia–pathophysiology, clinical features, and management. Ann Clin Lab Sci. 2004;34:131.PubMed Bhatt V, Saleem A. Review: drug-induced neutropenia–pathophysiology, clinical features, and management. Ann Clin Lab Sci. 2004;34:131.PubMed
7.
Zurück zum Zitat Johnston A, Uetrecht J. Current understanding of the mechanisms of idiosyncratic drug-induced agranulocytosis. Expert Opin Drug Met. 2015;11:243–57.CrossRef Johnston A, Uetrecht J. Current understanding of the mechanisms of idiosyncratic drug-induced agranulocytosis. Expert Opin Drug Met. 2015;11:243–57.CrossRef
8.
Zurück zum Zitat Ameri AH, Curtis BR, Sykes DB. Immune neutropenia mediated by micafungin. Am J Hematol. 2019;94:830–2.PubMed Ameri AH, Curtis BR, Sykes DB. Immune neutropenia mediated by micafungin. Am J Hematol. 2019;94:830–2.PubMed
9.
Zurück zum Zitat Andrès E, Federici L, Weitten T, Vogel T, Alt M. Recognition and management of drug-induced blood cytopenias: the example of drug-induced acute neutropenia and agranulocytosis. Expert Opin Drug Saf. 2008;7:481–9.CrossRef Andrès E, Federici L, Weitten T, Vogel T, Alt M. Recognition and management of drug-induced blood cytopenias: the example of drug-induced acute neutropenia and agranulocytosis. Expert Opin Drug Saf. 2008;7:481–9.CrossRef
10.
Zurück zum Zitat Andersohn F, Konzen C, Garbe E. Systematic review: agranulocytosis induced by nonchemotherapy drugs. Ann Intern Med. 2007;146:657–65.CrossRef Andersohn F, Konzen C, Garbe E. Systematic review: agranulocytosis induced by nonchemotherapy drugs. Ann Intern Med. 2007;146:657–65.CrossRef
11.
Zurück zum Zitat Atallah-Yunes SA, Ready A, Newburger PE. Benign ethnic neutropenia. Blood Rev. 2019;37:100586.CrossRef Atallah-Yunes SA, Ready A, Newburger PE. Benign ethnic neutropenia. Blood Rev. 2019;37:100586.CrossRef
12.
Zurück zum Zitat Fragiadaki I, Papadakis S, Sevastaki G, Sfyridaki K, Mavroudi I, Goulielmos GN, et al. Increased frequency of the single nucleotide polymorphism of the DARC/ACKR1 gene associated with ethnic neutropenia in a cohort of European patients with chronic idiopathic neutropenia. Am J Hematol. 2020;95:E163–6.CrossRef Fragiadaki I, Papadakis S, Sevastaki G, Sfyridaki K, Mavroudi I, Goulielmos GN, et al. Increased frequency of the single nucleotide polymorphism of the DARC/ACKR1 gene associated with ethnic neutropenia in a cohort of European patients with chronic idiopathic neutropenia. Am J Hematol. 2020;95:E163–6.CrossRef
13.
Zurück zum Zitat Reiner AP, Lettre G, Nalls MA, Ganesh SK, Mathias R, Austin MA, et al. Genome-wide association study of white blood cell count in 16,388 African Americans: the continental origins and genetic epidemiology network (COGENT). PloS Genet. 2011;7:e1002108.CrossRef Reiner AP, Lettre G, Nalls MA, Ganesh SK, Mathias R, Austin MA, et al. Genome-wide association study of white blood cell count in 16,388 African Americans: the continental origins and genetic epidemiology network (COGENT). PloS Genet. 2011;7:e1002108.CrossRef
14.
Zurück zum Zitat Calabretto G, Teramo A, Barilà G, Vicenzetto C, Gasparini VR, Semenzato G, et al. Neutropenia and large granular lymphocyte leukemia: from pathogenesis to therapeutic options. Cells (Basel, Switzerland). 2021;10:2800. Calabretto G, Teramo A, Barilà G, Vicenzetto C, Gasparini VR, Semenzato G, et al. Neutropenia and large granular lymphocyte leukemia: from pathogenesis to therapeutic options. Cells (Basel, Switzerland). 2021;10:2800.
15.
Zurück zum Zitat Karlsson J, Carlsson G, Larne O, Andersson M, Pütsep K. Vitamin D3 induces pro-LL-37 expression in myeloid precursors from patients with severe congenital neutropenia. J Leukocyte Biol. 2008;84:1279–86.CrossRef Karlsson J, Carlsson G, Larne O, Andersson M, Pütsep K. Vitamin D3 induces pro-LL-37 expression in myeloid precursors from patients with severe congenital neutropenia. J Leukocyte Biol. 2008;84:1279–86.CrossRef
16.
Zurück zum Zitat Xia J, Link DC. Severe congenital neutropenia and the unfolded protein response. Curr Opin Hematol. 2008;15:1–7.CrossRef Xia J, Link DC. Severe congenital neutropenia and the unfolded protein response. Curr Opin Hematol. 2008;15:1–7.CrossRef
17.
Zurück zum Zitat Nanua S, Murakami M, Xia J, Grenda DS, Woloszynek J, Strand M, et al. Activation of the unfolded protein response is associated with impaired granulopoiesis in transgenic mice expressing mutant Elane. Blood. 2011;117:3539–47.CrossRef Nanua S, Murakami M, Xia J, Grenda DS, Woloszynek J, Strand M, et al. Activation of the unfolded protein response is associated with impaired granulopoiesis in transgenic mice expressing mutant Elane. Blood. 2011;117:3539–47.CrossRef
18.
Zurück zum Zitat Corey SJ, Oyarbide U. New monogenic disorders identify more pathways to neutropenia: from the clinic to next-generation sequencing. Hematol Am Soc Hematol Educ Program. 2017;2017:172–80.CrossRef Corey SJ, Oyarbide U. New monogenic disorders identify more pathways to neutropenia: from the clinic to next-generation sequencing. Hematol Am Soc Hematol Educ Program. 2017;2017:172–80.CrossRef
19.
Zurück zum Zitat Spoor J, Farajifard H, Rezaei N. Congenital neutropenia and primary immunodeficiency diseases. Crit Rev Oncol Hematol. 2019;133:149–62.CrossRef Spoor J, Farajifard H, Rezaei N. Congenital neutropenia and primary immunodeficiency diseases. Crit Rev Oncol Hematol. 2019;133:149–62.CrossRef
20.
Zurück zum Zitat Nustede R, Klimiankou M, Klimenkova O, Kuznetsova I, Zeidler C, Welte K, et al. ELANE mutant-specific activation of different UPR pathways in congenital neutropenia. Br J Haematol. 2016;172:219–27.CrossRef Nustede R, Klimiankou M, Klimenkova O, Kuznetsova I, Zeidler C, Welte K, et al. ELANE mutant-specific activation of different UPR pathways in congenital neutropenia. Br J Haematol. 2016;172:219–27.CrossRef
21.
Zurück zum Zitat Rosenberg PS, Zeidler C, Bolyard AA, Alter BP, Bonilla MA, Dror Y, et al. Stable long-term risk of leukemia in patients with severe congenital neutropenia maintained on G-CSF therapy. Blood. 2009;114:3206.CrossRef Rosenberg PS, Zeidler C, Bolyard AA, Alter BP, Bonilla MA, Dror Y, et al. Stable long-term risk of leukemia in patients with severe congenital neutropenia maintained on G-CSF therapy. Blood. 2009;114:3206.CrossRef
22.
Zurück zum Zitat Germeshausen M, Schulze H, Kratz C, Wilkens L, Repp R, Shannon K, et al. An acquired G-CSF receptor mutation results in increased proliferation of CMML cells from a patient with severe congenital neutropenia. Leukemia. 2005;19:611–7.CrossRef Germeshausen M, Schulze H, Kratz C, Wilkens L, Repp R, Shannon K, et al. An acquired G-CSF receptor mutation results in increased proliferation of CMML cells from a patient with severe congenital neutropenia. Leukemia. 2005;19:611–7.CrossRef
23.
Zurück zum Zitat Germeshausen M, Ballmaier M, Schulze H, Welte K, Flohr T, Beiske K, et al. Granulocyte colony-stimulating factor receptor mutations in a patient with acute lymphoblastic leukemia secondary to severe congenital neutropenia. Blood. 2001;97:829–30.CrossRef Germeshausen M, Ballmaier M, Schulze H, Welte K, Flohr T, Beiske K, et al. Granulocyte colony-stimulating factor receptor mutations in a patient with acute lymphoblastic leukemia secondary to severe congenital neutropenia. Blood. 2001;97:829–30.CrossRef
24.
Zurück zum Zitat Aref S, El-Ghonemy M, Abouzeid T, El-Sabbagh A, El-Baiomy M. Prevalence and impact of colony stimulating factor 3 receptor (CSF3R) mutations among Egyptian acute myeloid leukemia patients. Leukemia Res. 2014;38:722–5.CrossRef Aref S, El-Ghonemy M, Abouzeid T, El-Sabbagh A, El-Baiomy M. Prevalence and impact of colony stimulating factor 3 receptor (CSF3R) mutations among Egyptian acute myeloid leukemia patients. Leukemia Res. 2014;38:722–5.CrossRef
25.
Zurück zum Zitat Skokowa J, Steinemann D, Katsman-Kuipers JE, Zeidler C, Klimenkova O, Klimiankou M, et al. Cooperativity of RUNX1 and CSF3R mutations in severe congenital neutropenia: a unique pathway in myeloid leukemogenesis. Blood. 2014;123:2229–37.CrossRef Skokowa J, Steinemann D, Katsman-Kuipers JE, Zeidler C, Klimenkova O, Klimiankou M, et al. Cooperativity of RUNX1 and CSF3R mutations in severe congenital neutropenia: a unique pathway in myeloid leukemogenesis. Blood. 2014;123:2229–37.CrossRef
26.
Zurück zum Zitat Rotulo GA, Beaupain B, Rialland F, Paillard C, Nachit O, Galambrun C, et al. HSCT may lower leukemia risk in ELANE neutropenia: a before-after study from the French Severe Congenital Neutropenia Registry. Bone Marrow Transplant. 2020;55:1614–22.CrossRef Rotulo GA, Beaupain B, Rialland F, Paillard C, Nachit O, Galambrun C, et al. HSCT may lower leukemia risk in ELANE neutropenia: a before-after study from the French Severe Congenital Neutropenia Registry. Bone Marrow Transplant. 2020;55:1614–22.CrossRef
27.
Zurück zum Zitat Skokowa J, Dale DC, Touw IP, Zeidler C, Welte K. Severe congenital neutropenias. Nat Rev Dis Primers. 2017;3:17032.CrossRef Skokowa J, Dale DC, Touw IP, Zeidler C, Welte K. Severe congenital neutropenias. Nat Rev Dis Primers. 2017;3:17032.CrossRef
28.
Zurück zum Zitat Frater JL. How I investigate neutropenia. Int J Lab Hematol. 2020;42:121–32.CrossRef Frater JL. How I investigate neutropenia. Int J Lab Hematol. 2020;42:121–32.CrossRef
29.
Zurück zum Zitat Dale DC. How I manage children with neutropenia. Br J Haematol. 2017;178:351–63.CrossRef Dale DC. How I manage children with neutropenia. Br J Haematol. 2017;178:351–63.CrossRef
30.
Zurück zum Zitat Christensen RD, Yoder BA, Baer VL, Snow GL, Butler A. Early-onset neutropenia in small-for-gestational-age infants. Pediatrics. 2015;136:e1259–67.CrossRef Christensen RD, Yoder BA, Baer VL, Snow GL, Butler A. Early-onset neutropenia in small-for-gestational-age infants. Pediatrics. 2015;136:e1259–67.CrossRef
31.
Zurück zum Zitat Delacour H, Mornand P, Larréché S, Pilo JE, Mérens A, Imbert P. A neonatal agranulocytosis. Clin Chem. 2014;60:719–22.CrossRef Delacour H, Mornand P, Larréché S, Pilo JE, Mérens A, Imbert P. A neonatal agranulocytosis. Clin Chem. 2014;60:719–22.CrossRef
32.
Zurück zum Zitat Fung YL, Pitcher LA, Taylor K, Minchinton RM. Managing passively acquired autoimmune neonatal neutropenia: a case study. Transfus Med. 2005;15:151–5.CrossRef Fung YL, Pitcher LA, Taylor K, Minchinton RM. Managing passively acquired autoimmune neonatal neutropenia: a case study. Transfus Med. 2005;15:151–5.CrossRef
33.
Zurück zum Zitat Zeidler C, Grote UAH, Nickel A, Brand B, Carlsson G, Cortesão E, et al. Outcome and management of pregnancies in severe chronic neutropenia patients by the European Branch of the Severe Chronic Neutropenia International Registry. Haematologica (Roma). 2014;99:1395–402.CrossRef Zeidler C, Grote UAH, Nickel A, Brand B, Carlsson G, Cortesão E, et al. Outcome and management of pregnancies in severe chronic neutropenia patients by the European Branch of the Severe Chronic Neutropenia International Registry. Haematologica (Roma). 2014;99:1395–402.CrossRef
34.
Zurück zum Zitat Bux J, Behrens G, Jaeger G, Welte K. Diagnosis and clinical course of autoimmune neutropenia in infancy: analysis of 240 cases. Blood. 1998;91:181–6.CrossRef Bux J, Behrens G, Jaeger G, Welte K. Diagnosis and clinical course of autoimmune neutropenia in infancy: analysis of 240 cases. Blood. 1998;91:181–6.CrossRef
35.
Zurück zum Zitat Porretti L, Farruggia P, Colombo FS, Cattaneo A, Ghilardi R, Mirra N, et al. Diagnostic value of cell bound and circulating neutrophil antibody detection in pediatric neutropenia. Pediatr Blood Cancer. 2018;65:e26904.CrossRef Porretti L, Farruggia P, Colombo FS, Cattaneo A, Ghilardi R, Mirra N, et al. Diagnostic value of cell bound and circulating neutrophil antibody detection in pediatric neutropenia. Pediatr Blood Cancer. 2018;65:e26904.CrossRef
36.
Zurück zum Zitat Farruggia P, Dufour C. Diagnosis and management of primary autoimmune neutropenia in children: insights for clinicians. Ther Adv Hematol. 2015;6:15–24.CrossRef Farruggia P, Dufour C. Diagnosis and management of primary autoimmune neutropenia in children: insights for clinicians. Ther Adv Hematol. 2015;6:15–24.CrossRef
37.
Zurück zum Zitat Jinca C, Serban M, Ursu E, Munteanu A, Arghirescu S. Primary autoimmune neutropenia of infancy and childhood in a cohort of patients from western Romania. Exp Ther Med. 2021;21:280.CrossRef Jinca C, Serban M, Ursu E, Munteanu A, Arghirescu S. Primary autoimmune neutropenia of infancy and childhood in a cohort of patients from western Romania. Exp Ther Med. 2021;21:280.CrossRef
38.
Zurück zum Zitat Dale DC, Bolyard A, Marrero T, Makaryan V, Bonilla M, Link DC, et al. Long-term effects of G-CSF therapy in cyclic neutropenia. N Engl J Med. 2017;377:2290–2.CrossRef Dale DC, Bolyard A, Marrero T, Makaryan V, Bonilla M, Link DC, et al. Long-term effects of G-CSF therapy in cyclic neutropenia. N Engl J Med. 2017;377:2290–2.CrossRef
Metadaten
Titel
Neutropenia: diagnosis and management
verfasst von
Jing Zhang
Xiao-Yan Wu
Run-Ming Jin
Publikationsdatum
12.08.2022
Verlag
Springer Nature Singapore
Erschienen in
World Journal of Pediatrics / Ausgabe 11/2022
Print ISSN: 1708-8569
Elektronische ISSN: 1867-0687
DOI
https://doi.org/10.1007/s12519-022-00593-7

Weitere Artikel der Ausgabe 11/2022

World Journal of Pediatrics 11/2022 Zur Ausgabe

Neuer Typ-1-Diabetes bei Kindern am Wochenende eher übersehen

23.04.2024 Typ-1-Diabetes Nachrichten

Wenn Kinder an Werktagen zum Arzt gehen, werden neu auftretender Typ-1-Diabetes und diabetische Ketoazidosen häufiger erkannt als bei Arztbesuchen an Wochenenden oder Feiertagen.

Neue Studienergebnisse zur Myopiekontrolle mit Atropin

22.04.2024 Fehlsichtigkeit Nachrichten

Augentropfen mit niedrig dosiertem Atropin können helfen, das Fortschreiten einer Kurzsichtigkeit bei Kindern zumindest zu verlangsamen, wie die Ergebnisse einer aktuellen Studie mit verschiedenen Dosierungen zeigen.

Spinale Muskelatrophie: Neugeborenen-Screening lohnt sich

18.04.2024 Spinale Muskelatrophien Nachrichten

Seit 2021 ist die Untersuchung auf spinale Muskelatrophie Teil des Neugeborenen-Screenings in Deutschland. Eine Studie liefert weitere Evidenz für den Nutzen der Maßnahme.

Fünf Dinge, die im Kindernotfall besser zu unterlassen sind

18.04.2024 Pädiatrische Notfallmedizin Nachrichten

Im Choosing-Wisely-Programm, das für die deutsche Initiative „Klug entscheiden“ Pate gestanden hat, sind erstmals Empfehlungen zum Umgang mit Notfällen von Kindern erschienen. Fünf Dinge gilt es demnach zu vermeiden.

Update Pädiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.